# Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides

> **NCT01964976** · — · COMPLETED · sponsor: **Takeda** · enrollment: 1096 (actual)

## Conditions studied

- Surveillance

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01964976
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 1096 (ACTUAL)
- **Last updated:** 2017-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01964976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01964976, "Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01964976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*